Dye Capital Cann Holdings, II 4

4 · Medicine Man Technologies, Inc. · Filed Jun 8, 2021

Insider Transaction Report

Form 4
Period: 2020-12-16
Transactions
  • Purchase

    Series A Cumulative Convertible Preferred Stock

    2020-12-16$1000.00/sh+7,700$7,700,0007,700 total
    Exercise: $1.20Common Stock (6,416,667 underlying)
  • Purchase

    Series A Cumulative Convertible Preferred Stock

    2021-02-25$1000.00/sh+1,300$1,300,00014,850 total
    Exercise: $1.20Common Stock (1,083,333 underlying)
  • Purchase

    Series A Cumulative Convertible Preferred Stock

    2020-12-22$1000.00/sh+1,300$1,300,00010,450 total
    Exercise: $1.20Common Stock (1,083,333 underlying)
  • Purchase

    Series A Cumulative Convertible Preferred Stock

    2021-03-30$1000.00/sh+4,000$4,000,00021,350 total
    Exercise: $1.20Common Stock (3,333,333 underlying)
  • Purchase

    Series A Cumulative Convertible Preferred Stock

    2021-03-02$1000.00/sh+2,500$2,500,00017,350 total
    Exercise: $1.20Common Stock (2,083,333 underlying)
  • Purchase

    Series A Cumulative Convertible Preferred Stock

    2021-02-03$1000.00/sh+3,100$3,100,00013,550 total
    Exercise: $1.20Common Stock (2,583,333 underlying)
  • Purchase

    Series A Cumulative Convertible Preferred Stock

    2020-12-18$1000.00/sh+1,450$1,450,0009,150 total
    Exercise: $1.20Common Stock (1,208,333 underlying)
Footnotes (3)
  • [F1]Subject to adjustment, as described in the Certificate of Designation.
  • [F2]The shares of Series A Cumulative Convertible Preferred Stock (the "Series A Preferred Shares") are convertible into shares of the common stock (the "Common Shares") of Medicine Man Technologies, Inc. (the "Company") upon the events specified in the Company's Certificate of Designation of Series A Cumulative Convertible Preferred Stock (the "Certificate of Designation"). The Preferred stock is perpetual and therefore has no expiration date.
  • [F3]Represents the number of Common Shares issuable upon conversion of the Series A Preferred Shares on the date of the reported transaction. Each Series A Preferred Share is convertible into that number of Common Shares equal to the preference amount (initially $1,000) plus any accrued dividends with respect to such share, divided by the conversion price (initially $1.20), subject to adjustment as set forth in the Certificate of Designation. The Series A Preferred Shares earn a cumulative dividend of 8% per annum.

Documents

1 file
  • 4
    ownership.xmlPrimary